This page shows you the latest news items in this category.
Total 127760 results found since Jan 2013.
Seagen Pops After Scoring A ' Must-Win ' For Its $43 Billion Pfizer Takeover
A bladder cancer treatment tied to a quartet of biopharma companies — including Pfizer (PFE) and buyout target Seagen (SGEN) — succeeded in a final-phase study on Friday, leading SGEN stock to surge. The companies added Merck's (MRK) Keytruda on top of Seagen and Astellas Pharma's (ALPMY) Padcev…#pfe #sgen #merck #seagen #astellaspharma #alpmy #isi #umerraffat #pfizer #padcev
Source: Reuters: Health - September 23, 2023 Category: Consumer Health News Source Type: news
Months after hospitalization for COVID-19, MRIs reveal multiorgan damage
This study found abnormal MRI results in 20% to 25% of both controls and hospitalized patients, suggesting
“a lot of these cardiac abnormalities that were seen in the COVID group must have been there beforehand.” Post–COVID-19 patients with lingering cardiac symptoms might have disorders like heartbeat irregularities that aren’t always visible with MRI, or dysfunction in other organs, he adds.
Although it can offer clues to an organ’s health, MRI is an imperfect measure of how a patient is faring after infection. Researchers found no connection between abnormal liver MRIs and symptoms such as gastroin...
Source: ScienceNOW - September 22, 2023 Category: Science Source Type: news
New life extending treatment gives blood cancer patients an extra five years
Blood cancer will be given the chance of an extra five years with a new three-drug combination called DRD.
Source: Daily Express - Health - September 22, 2023 Category: Consumer Health News Source Type: news
Goodyear Tire to cut 700 jobs, sell retail stores in Asia Pacific
Goodyear Tire & Rubber (GT.O) said on Friday it plans to cut 700 jobs and sell about 100 retail stores and fleet locations, under a rationalization plan for its Asia Pacific segment. The move is expected to improve the segment's operating income by approximately $50 million to $55 million in 2025,…#goodyeartirerubber #asiapacific #newzealand #middleeast #africa #ohio
Source: Reuters: Health - September 22, 2023 Category: Consumer Health News Source Type: news
Japan set to approve Alzheimer ' s drug Leqembi as soon as Monday
TOKYO -- Japan's health ministry is preparing to formally approve as early as Monday the manufacture and sale of an Alzheimer's drug developed by Japanese pharmaceutical company Eisai and U.S. partner Biogen. Lecanemab, marketed as Leqembi, will be Japan's first treatment for the disease that has…#tokyo #eisai #biogen #leqembi
Source: Reuters: Health - September 22, 2023 Category: Consumer Health News Source Type: news
FDA advisors unanimously reject Intarcia ' s embattled type 2 diabetes treatment
I2o Therapeutics CEO Kurt Graves set out on Thursday to make a case to a panel of the FDA’s expert advisors that the benefits of his company’s twice-rejected implant to treat type 2 diabetes outweigh its risks — but the committee wasn’t convinced. The FDA’s Endocrinologic…#kurtgraves #fda #2diabetes #metabolic #unlock
Source: Reuters: Health - September 22, 2023 Category: Consumer Health News Source Type: news
AstraZeneca Surges As It Takes A Shot At Gilead ' s Second-Biggest Cancer Drug
and Daiichi Sankyo said Friday their breast cancer treatment outperformed chemotherapy in a Phase 3 study, and AZN stock jumped to its 50-day line. The companies are in the antibody drug conjugate, or ADC, space with a medicine called datopotamab deruxteca. ADCs are like smart bombs, targeting…#daiichisankyo #azn #astrazeneca #adc #marketsmithcom #trodelvy #gileadsciences #gild #isi #umerraffat
Source: Reuters: Health - September 22, 2023 Category: Consumer Health News Source Type: news
Pitt gets at least $34M for study to improve treatment of bleeding in children
"This trial will be transformative when it comes to trauma care for children," says one of the principal investigators.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 22, 2023 Category: Pharmaceuticals Authors: Paul J. Gough Source Type: news
Minneapolis plans to transfer city property to Native American tribe for treatment center
Minneapolis officials plan to transfer two city-owned properties to the Red Lake Band of Chippewa
Source: ABC News: Health - September 22, 2023 Category: Consumer Health News Tags: Health Source Type: news
Hyperbaric Oxygen Therapy for TBI: Wishful Thinking? Hyperbaric Oxygen Therapy for TBI: Wishful Thinking?
A recent review recommending HBOT for traumatic brain injury prompted this neurologist to revisit a treatment he trained in decades ago.Medscape Neurology
Source: Medscape Neurology and Neurosurgery Headlines - September 22, 2023 Category: Neurology Tags: Neurology & Neurosurgery Expert Column Source Type: news
Amoxicillin Alone for Acute Sinusitis Holds Up Against Broad-Spectrum Cousin
(MedPage Today) -- Treatment failure with amoxicillin-clavulanate for pediatric acute sinusitis was similar compared with amoxicillin alone, but the broad-spectrum antibiotic may be associated with more adverse events, an examination of a large...
Source: MedPage Today Public Health - September 22, 2023 Category: American Health Source Type: news
NICE moves CVD advice closer to QOF and updates treatment escalation options
NICE draft guidance on cardiovascular disease backs a new target for lipid levels for secondary prevention and offers advice on escalating treatment for people on statins.
Source: GP Online News - September 22, 2023 Category: Primary Care Tags: Clinical News Source Type: news
No brain, no problem. Jellyfish learn just fine
When it comes to learned behavior, even the simplest minds are capable of advanced thought. The Caribbean box jellyfish (
Tripedalia cystophora
), which doesn’t even have a brain, can alter its behavior based on past experiences, new research reveals. Scientists believe the creature uses this learning ability along with its astoundingly complex visual system to navigate the murky mangrove swamps it calls home.
Scientists have known for some time that animals in the phylum Cnidaria—which includes jellyfish, corals, and sea anemones—are capable of basic forms of learning when repeatedly presented with a stim...
Source: ScienceNOW - September 22, 2023 Category: Science Source Type: news
Cognitive-Behavioral Therapy Helps Relieve Fibromyalgia Pain
FRIDAY, Sept. 22, 2023 -- Cognitive-behavioral therapy (CBT) is superior to a matched education treatment in reducing the interfering effects of pain and other aspects of fibromyalgia, according to a study published online Sept. 20 in Arthritis...
Source: Drugs.com - Pharma News - September 22, 2023 Category: Pharmaceuticals Source Type: news
FDA Approves Another SGLT2 Inhibitor for Treating CKD
(MedPage Today) -- The SGLT2 inhibitor empagliflozin (Jardiance) nabbed a new indication for the treatment of adults with chronic kidney disease (CKD) regardless of diabetes status, Boehringer Ingelheim and Eli Lilly announced.
Data from the phase...
Source: MedPage Today Cardiovascular - September 22, 2023 Category: Cardiology Source Type: news
